XML 64 R57.htm IDEA: XBRL DOCUMENT v3.25.3
Commitments and Contingencies - Additional Information (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Jun. 30, 2022
Jan. 31, 2021
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Lilly Agreement            
Loss Contingencies [Line Items]            
Upfront payment   $ 5,000,000        
Royalties incurred         $ 0  
Lilly Agreement | Maximum            
Loss Contingencies [Line Items]            
Tiered percentage royalty on annual net sales   10.00%        
Akoya Agreement            
Loss Contingencies [Line Items]            
Upfront payment $ 600,000          
Obligation to pay upon achievement of specified development milestones $ 20,300,000          
Milestone payments         18,200,000  
Research and Development Expense | Akoya Agreement            
Loss Contingencies [Line Items]            
Milestones expenses     $ 0 $ 4,500,000 $ 1,200,000 $ 6,300,000
Development and Commercial Milestone | Lilly Agreement            
Loss Contingencies [Line Items]            
Milestone payments   $ 168,000,000